{"id":"https://openalex.org/W2051084702","doi":"https://doi.org/10.1158/1535-7163.mct-05-0259","title":"Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels","display_name":"Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2051084702","doi":"https://doi.org/10.1158/1535-7163.mct-05-0259","mag":"2051084702","pmid":"https://pubmed.ncbi.nlm.nih.gov/16432168"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-05-0259","doi":"https://doi.org/10.1158/1535-7163.mct-05-0259","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-05-0259","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038223232","display_name":"Robert A. Wild","orcid":"https://orcid.org/0000-0002-1298-265X","observed_orcids":["https://orcid.org/0000-0002-1298-265X"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Wild","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","Bristol-Myers Squibb Co., Oncology Drug Discovery, P.O. Box 4000, Mailstop K23-03, Princeton, NJ 08543-4000, USA. robert.wild@bms.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Bristol-Myers Squibb Co., Oncology Drug Discovery, P.O. Box 4000, Mailstop K23-03, Princeton, NJ 08543-4000, USA. robert.wild@bms.com","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051367332","display_name":"Krista Fager","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krista Fager","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055799863","display_name":"Christine Flefleh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Flefleh","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084542555","display_name":"David Kan","orcid":"https://orcid.org/0009-0008-0636-3124","observed_orcids":["https://orcid.org/0009-0008-0636-3124"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Kan","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003411418","display_name":"Ivan V. Inigo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ivan Inigo","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086417693","display_name":"Stephen Castaneda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Castaneda","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102007098","display_name":"Feng Roger Luo","orcid":"https://orcid.org/0000-0001-6272-5005","observed_orcids":["https://orcid.org/0000-0001-6272-5005"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Feng (Roger) Luo","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083967440","display_name":"Amy Camuso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Camuso","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027215276","display_name":"Kelly McGlinchey","orcid":"https://orcid.org/0000-0002-4969-5523","observed_orcids":["https://orcid.org/0000-0002-4969-5523"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly McGlinchey","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103002200","display_name":"William C. Rose","orcid":"https://orcid.org/0000-0003-1582-0856","observed_orcids":["https://orcid.org/0000-0003-1582-0856"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William C. Rose","raw_affiliation_strings":["Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co., Pharmaceutical Research Institute, Oncology Drug Discovery, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":null,"apc_paid":null,"fwci":3.1844,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":{"value":0.91574627,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"5","issue":"1","first_page":"104","last_page":"113"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.01850000023841858,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9570000171661377},{"id":"https://openalex.org/keywords/egfr-phosphorylation","display_name":"EGFR phosphorylation","score":0.7680000066757202},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6779999732971191},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7269999980926514},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9620000123977661},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9300000071525574},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6309999823570251},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9939674735069275},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6590595841407776},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6447573900222778},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5565130114555359},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.5338239669799805},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4894667863845825},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4478168487548828},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42668551206588745},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3635967969894409},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.35785236954689026},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34448501467704773},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33789557218551636},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3040323853492737},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.17568078637123108},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-05-0259","doi":"https://doi.org/10.1158/1535-7163.mct-05-0259","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-05-0259","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:16432168","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16432168","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.979200005531311,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W78580487","https://openalex.org/W135877420","https://openalex.org/W1569865130","https://openalex.org/W1580361048","https://openalex.org/W1664817186","https://openalex.org/W1970476748","https://openalex.org/W1977332018","https://openalex.org/W1978389896","https://openalex.org/W1983104536","https://openalex.org/W1988442083","https://openalex.org/W2008803651","https://openalex.org/W2016710415","https://openalex.org/W2025313715","https://openalex.org/W2027230571","https://openalex.org/W2043696829","https://openalex.org/W2048454485","https://openalex.org/W2051120695","https://openalex.org/W2081284509","https://openalex.org/W2082870362","https://openalex.org/W2088658971","https://openalex.org/W2090871977","https://openalex.org/W2096287391","https://openalex.org/W2097382995","https://openalex.org/W2098487639","https://openalex.org/W2101778620","https://openalex.org/W2102897408","https://openalex.org/W2105499277","https://openalex.org/W2106764013","https://openalex.org/W2110860588","https://openalex.org/W2116150263","https://openalex.org/W2116175718","https://openalex.org/W2122885616","https://openalex.org/W2123967535","https://openalex.org/W2126055089","https://openalex.org/W2139236349","https://openalex.org/W2142442804","https://openalex.org/W2142564546","https://openalex.org/W2142889189","https://openalex.org/W2143594378","https://openalex.org/W2153534791","https://openalex.org/W2158863975","https://openalex.org/W2159227997","https://openalex.org/W2159506251","https://openalex.org/W2161821474","https://openalex.org/W2168377135","https://openalex.org/W2170517479","https://openalex.org/W2188010225","https://openalex.org/W2268171795","https://openalex.org/W2284799106","https://openalex.org/W2408136432"],"related_works":["https://openalex.org/W2084318900","https://openalex.org/W2020359797","https://openalex.org/W2158155247","https://openalex.org/W2116246337","https://openalex.org/W1803620880","https://openalex.org/W2167064662","https://openalex.org/W2129432386","https://openalex.org/W4248240344","https://openalex.org/W2048791004","https://openalex.org/W2075451702"],"abstract_inverted_index":{"Although":[0],"Erbitux":[1],"(cetuximab)":[2],"has":[3],"proven":[4],"therapeutic":[5,166],"benefit":[6],"in":[7,42,92,107,153,170,201,234],"the":[8,11,28,46,67,93,108,120,154,171,202,245],"clinical":[9],"setting,":[10],"molecular":[12],"determinants":[13],"predicting":[14],"responsiveness":[15,47],"to":[16,48,81,101,145,194,251],"this":[17,249],"agent":[18,250],"are":[19],"still":[20],"not":[21,221],"very":[22],"well":[23],"understood.":[24],"Here,":[25],"we":[26],"assessed":[27],"relationship":[29],"between":[30],"basal":[31,226],"total":[32,229],"and":[33,45,71,95,115,138,173,208],"activated":[34,231],"(pY1068)":[35,232],"epidermal":[36],"growth":[37,68],"factor":[38],"receptor":[39],"(EGFR)":[40],"levels":[41,127,227],"a":[43,75,235],"tumor":[44,159],"cetuximab":[49,99,133,174,188,203,218,242],"monotherapy":[50,219],"or":[51,230],"combination-based":[52],"treatment":[53,59],"using":[54],"human":[55],"xenograft":[56],"models.":[57,117,210],"Cetuximab":[58],"alone":[60],"(0.25-1":[61],"mg/mouse/injection,":[62,135,190],"q3d,":[63],"i.p.)":[64,137,192],"effectively":[65],"delayed":[66],"of":[69,77,86,119,128,181,228],"GEO":[70,158],"L2987":[72],"tumors":[73,122],"by":[74,241],"minimum":[76],"10":[78],"days":[79],"corresponding":[80],"log":[82],"cell":[83],"kill":[84],"values":[85],">or=1.0.":[87],"Borderline":[88],"activity":[89,106,215,240],"was":[90,168],"seen":[91],"A549":[94,177],"WiDr":[96,209],"xenografts.":[97],"However,":[98,164],"failed":[100,193],"show":[102,195],"any":[103,196],"significant":[104],"antitumor":[105,254],"HT29,":[109,206],"HCT116,":[110],"LOVO,":[111],"Colo205,":[112],"LX-1,":[113],"HCC70,":[114],"N87":[116],"All":[118],"studied":[121],"had":[123],"detectable":[124],"yet":[125,156],"variable":[126],"EGFR.":[129],"For":[130],"combination":[131],"regimens,":[132],"(1":[134,189],"q3dx5,":[136,142,185,191],"cisplatin":[139,172],"(4.5":[140],"mg/kg/injection,":[141,184],"i.v.)":[143,186],"proved":[144],"be":[146,244],"significantly":[147],"more":[148],"efficacious":[149],"than":[150],"individual":[151,199],"monotherapies":[152,200],"cisplatin-refractory":[155],"cetuximab-responsive":[157],"model":[160],"(P":[161],"<":[162],"0.001).":[163],"no":[165],"enhancement":[167],"observed":[169],"weakly":[175],"responsive":[176,205],"xenograft.":[178],"Similarly,":[179],"combinations":[180],"CPT-11":[182],"(48":[183],"with":[187,217,224],"improvements":[197],"over":[198],"resistant/weakly":[204],"A549,":[207],"We":[211],"conclude":[212],"that":[213],"preclinical":[214],"associated":[216],"does":[220],"correlate":[222],"directly":[223],"relative":[225],"EGFR":[233],"tumor.":[236],"Moreover,":[237],"robust":[238],"single-agent":[239],"may":[243],"best":[246],"predictor":[247],"for":[248],"potentiate":[252],"chemotherapy-mediated":[253],"activities.":[255]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":9}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}